• Return to Headlines

Lemaitre Vascula Shares Up 9.8% Since SmarTrend's Buy Recommendation (LMAT)

By David Diaz

SmarTrend identified an Uptrend for Lemaitre Vascula (NASDAQ:LMAT) on July 16th, 2019 at $29.43. In approximately 4 weeks, Lemaitre Vascula has returned 9.75% as of today's recent price of $32.30.

Over the past year, Lemaitre Vascula has traded in a range of $21.79 to $38.99 and is now at $32.30, 48% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.2% while the 200-day MA has risen 0.2%.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Lemaitre Vascula shares.

Log in and add Lemaitre Vascula (LMAT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights lemaitre vascula

Ticker(s): LMAT